The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex
NCT00002011 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).
Conditions
- HIV Infections
Interventions
- DRUG
-
Methoxsalen
Sponsors & Collaborators
-
Therakos
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness of the Drug DPC 083 in Combination With Nucleoside Analogue Reverse Transcriptase Inhibitors in HIV-1-Infected Patients Who Are Failing Treatment With Nonnucleoside Reverse Transcriptase Inhibitors
NCT00007449 ·Status: UNKNOWN ·Phase: PHASE2
-
Depot Disulfiram for AIDS and ARC
NCT00002065 ·Status: COMPLETED ·Phase: NA
-
A Pharmacologically Guided Phase I/II Study of Daily Orally Administered Synthetic Hypericin in HIV-Infected Subjects
NCT00000792 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DTC in Patients With AIDS and AIDS Related Complex
NCT00002069 ·Status: COMPLETED ·Phase: NA
-
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
NCT00708110 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of WF 10 IV Solution in Patients With Advanced HIV Disease
NCT00002152 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients
NCT00002385 ·Status: COMPLETED ·Phase: NA
-
A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease
NCT00002337 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Clearance Of PF-04776548 From The Body Following A Very Low (Micro) Dose Of The Compound Using A Low Level Of Radiotracer To Help Quantify Expected Low Concentrations Of PF-04776548 In The Body
NCT01045317 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of CI-1012 in HIV-Infected Patients
NCT00002196 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.
NCT00002111 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Itraconazole in Patients With Advanced HIV Infection
NCT00002370 ·Status: COMPLETED ·Phase: NA
-
A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia
NCT00000724 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides
NCT00002114 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety and Effects of Repeated Doses of 3BNC117-LS and 10-1074-LS on Persistent Viral Reservoirs in People Living With HIV and on Suppressive Antiretroviral Therapy
NCT05612178 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Study Comparing 4 Doses Of GW810781 Versus Placebo In HIV-Infected Patients
NCT00046332 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex
NCT00000692 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
NCT00000812 ·Status: COMPLETED ·Phase: PHASE1
-
Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
NCT00002104 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue
NCT00775294 ·Status: COMPLETED ·Phase: PHASE1
-
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
NCT00000764 ·Status: COMPLETED ·Phase: PHASE1
-
Pre-Exposure Prophylaxis Using TMC278LA
NCT01049932 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Safety and Effectiveness of 935U83 in HIV-Infected Patients
NCT00002338 ·Status: COMPLETED ·Phase: PHASE1
-
UB-421 Combine With Optimized Background Therapy Regimen in Multi-Drug Resistant HIV-1 Infection Patients
NCT03164447 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89
NCT00002141 ·Status: COMPLETED ·Phase: PHASE1